Quick Comparison

NALTSulbutiamine
Half-Life2-3 hours5 hours
Typical DosageStandard: 300-600 mg NALT 1-2 times daily. Alternatively, plain L-Tyrosine at 500-2000 mg daily (better studied but less water-soluble). Best taken on an empty stomach 30 minutes before a stressful task.Standard: 200-600 mg daily in 1-2 doses. Take with food (fat-soluble). Tolerance can develop with daily use — best cycled or used intermittently.
AdministrationOral (capsules, powder). Take on an empty stomach for best absorption.Oral (capsules, tablets). Fat-soluble — take with food.
Research Papers10 papers10 papers
Categories

Mechanism of Action

NALT

NALT (N-acetyl L-tyrosine) is deacetylated by aryl acylamidase in the gut and liver to release L-Tyrosine. Tyrosine is hydroxylated to L-DOPA by tyrosine hydroxylase (TH) — the rate-limiting step in catecholamine synthesis, requiring tetrahydrobiopterin as cofactor. L-DOPA is decarboxylated by aromatic L-amino acid decarboxylase (AADC) to dopamine; dopamine is converted to norepinephrine by dopamine beta-hydroxylase (DBH), and norepinephrine to epinephrine by phenylethanolamine N-methyltransferase (PNMT). Under stress or sleep deprivation, catecholamine stores in noradrenergic and dopaminergic neurons deplete rapidly. Supplemental tyrosine provides substrate to maintain synthesis when demand exceeds supply, supporting prefrontal cortex function and working memory.

Sulbutiamine

Sulbutiamine consists of two thiamine (vitamin B1) molecules connected by a disulfide bridge, conferring lipophilicity and efficient blood-brain barrier penetration via passive diffusion. In the brain, it is hydrolyzed to thiamine and increases thiamine diphosphate (TDP) levels—the cofactor for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and transketolase, enzymes critical for glucose metabolism and the Krebs cycle. Sulbutiamine upregulates D1 dopamine receptors in the prefrontal cortex, possibly through reduced receptor internalization or increased expression. It modulates glutamatergic transmission (affecting NMDA/AMPA receptor function) and enhances cholinergic transmission. The anti-fatigue and memory-enhancing effects likely stem from improved neuronal glucose oxidation, increased ATP production, and enhanced dopaminergic and cholinergic tone in cognitive circuits.

Risks & Safety

NALT

Common

Mild nausea on empty stomach, headache, heartburn.

Serious

May trigger hypertensive crisis in people taking MAOIs. Avoid with thyroid disorders without medical guidance.

Rare

Insomnia, anxiety, heart palpitations at high doses.

Sulbutiamine

Common

Headache, insomnia, irritability, nausea. Tolerance develops with daily use.

Serious

No serious adverse effects documented.

Rare

Skin rash, mood instability, agitation.

Full Profiles